PLK1-IN-15
PLK1-IN-15 (Compound 7n) is a PLK1 inhibitor (IC50: 38.5 nM) . PLK1-IN-15 exhibits antiproliferative activity against HepG2, Huh7, H1299 and A549 cells (IC50: 2.03, 2.08, 4.79 and 17.11 μM, respectively) . PLK1-IN-15 induces cell cycle arrest at the G2/M phase and apoptosis, and has anticancer activity[1].
Product Specifications
CAS Number
[3068529-37-0]
UNSPSC
12352211
Target
Apoptosis; Polo-like Kinase (PLK)
Related Pathways
Apoptosis; Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
O=C(OC)C1=C(SC2=C1CCCC2)NC3=NC(NC4=CC=C(N5CCN(C)CC5)C=C4)=NC=C3[N+]([O-])=O
Molecular Formula
C25H29N7O4S
Molecular Weight
523.61
References & Citations
[1]Ai M, et al. Design, synthesis and evaluation of novel cycloalkylthiophene-based aminopyrimidine derivatives as potent PLK1 inhibitors. Bioorg Med Chem Lett. 2025 Aug 15;124:130260.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PLK1
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
P9004-36A-FITC 200 µL
PRMT8, CT (Protein Arginine N-methyltransferase 8, Heterogeneous Nuclear Ribonucleoprotein Methyltransferase-like Protein 4, HRMT1L3, HRMT1L4) (FITC) discontinued
Ask
View Details 
RDR-SCARB1-Hu-01 96 Tests
Human Scavenger Receptor Class B Member 1 (SCARB1) ELISA Kit
Ask
View Details 
RDR-SCARB1-Hu-02 48 Tests
Human Scavenger Receptor Class B Member 1 (SCARB1) ELISA Kit
Ask
View Details